Vascular access for long-term use: AV fistula and AV graft

Surgical methods
Number of report

Ask the expert

(we accept only company emails)

The report presents a summary of the reimbursement situation for creation of vascular access for long-term use in Europe. Report includes creation of AV fistula and placement of AV graft.  

Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations). 

The only reimbursement within public / statutory health insurance systems is considered.

The report includes essential information about reimbursement, including:

  • Brief country-specific overview of reimbursement system
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions on indications or scenarios for the use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • Finland
  • France
  • Germany
  • Italy
  • The Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for vascular access for long-term use include:

  • B. Braun – AV Fistula Needles with MasterGuard anti-stick needle protector
  • Browndove - Pristine AV Fistula needle
  • CR Bard - LUTONIX 035 DCB – Dysfunctional AV Fistula Indication; VECTRA, VENAFLO II, CARBOFLO, IMPRA Vascular Grafts; FLUENCY Plus Endovascular Stent Graft
  • Dialife – Butterfly AV Fistula Needle
  • Farmasol - Diarenneedle A.V. Fistula Needle Set
  • Fresenius – Nipro, JMS Fistula Needles
  • Global Medikit – Glofin AV Fistula Needle set
  • Global Meditronic - AV Fistula Needles
  • Gore - GORE ACUSEAL Vascular Graft
  • Guangdong Baihe Medical Technology – AV Fistula Needle; Long Term Hemodialysis Catheter
  • Hospitech - AV Fistula Needles
  • InnAVasc - AV Graft
  • JMS North America Corporation – AV Fistula Needles – SysLocMINI, SysLoc, WingEater, Harmony
  • Laminate Medical Technologies - VasQ
  • Maquet - FLIXENE Vascular Grafts
  • Merit Medical - HeRO Graft
  • Nipro Medical Corporation - Tulip Safety Fistula Needles
  • NxStage Medical - AV Fistula Needles
  • Perfect Medical - AV fistula needles set
  • PolyMed - AV Fistula Needles
  • Rudraksh Pharma & Surgico - AV Fistula Needles
  • TVA Medical - everlinQ endoAVF System
  • Vascular Flow Technologies - Spiral Flow AV Graft
  • Vascular Genesis – HYDRA graft
  • Vascutek Terumo - Rapidax graft
  • Wesley Biotech - AV Fistula Needle Sets

Table of content is not available at this moment.


Feb 2023

In January and February 2023, Ordering Forum for the “New Methods” framework invited interested parties regarding several technologies proposed for evaluation within the framework. The technologies concern arteriovenous fistula for hemodialysis, deep brain stimulation, epidural spinal cord stimulation, and digital chest drain. Ordering Forum will decide whether the technology undergoes evaluation at the national level.

Read more


Feb 2023

On January 30, 2023, the Institute for the Hospital Remuneration System (InEK) published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2022. The medical technologies belonging to the cardiovascular, eHealth, gastrointestinal, neuromodulation, neurovascular, peripheral vascular, orthopedic, and other technology groups obtained positive status 1.

Read more


Nov 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Read more


Oct 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in September 2022. Thirty-eight recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular and peripheral vascular, neurovascular and neuromodulation, orthopedic, endocrine, ENT, dermatological, and spine-related devices, as well as digital care and medical aids.

Read more


Sep 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 15937 of August 4, 2022, Tuscany Regional Healthcare has published assessments of six medical devices in various therapeutic areas, such as cardiovascular and peripheral vascular areas, neurovascular procedures, gastroenterology, and dermatology.

Read more
(we accept only company emails)